Global Artificial Heart and Assist Devices Market Research Report 2023

Publication ID:

PB503236640

Publication Date:

March 10, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Highlights
The global Artificial Heart and Assist Devices market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Artificial Heart and Assist Devices is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Artificial Heart and Assist Devices is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Artificial Heart and Assist Devices in Cardiac Surgery is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Artificial Heart and Assist Devices include BiVACOR, SynCardia, Jarvik Heart, CARMAT, AbioMed, LivaNova (Sorin), Getinge (Maquet), Medtronic and Terumo CV Group, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Heart and Assist Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Heart and Assist Devices.
The Artificial Heart and Assist Devices market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Artificial Heart and Assist Devices market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Heart and Assist Devices companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
BiVACOR
SynCardia
Jarvik Heart
CARMAT
AbioMed
LivaNova (Sorin)
Getinge (Maquet)
Medtronic
Terumo CV Group
Braile Biomedica
Tianjin Medical
Segment by Type
Artificial Heart Lung Machines
Artificial Heart
Segment by Application
Cardiac Surgery
Acute Respiratory Failure Treatment
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Heart and Assist Devices companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Heart and Assist Devices Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Artificial Heart Lung Machines
1.2.3 Artificial Heart
1.3 Market by Application
1.3.1 Global Artificial Heart and Assist Devices Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cardiac Surgery
1.3.3 Acute Respiratory Failure Treatment
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Heart and Assist Devices Market Perspective (2018-2029)
2.2 Artificial Heart and Assist Devices Growth Trends by Region
2.2.1 Global Artificial Heart and Assist Devices Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Artificial Heart and Assist Devices Historic Market Size by Region (2018-2023)
2.2.3 Artificial Heart and Assist Devices Forecasted Market Size by Region (2024-2029)
2.3 Artificial Heart and Assist Devices Market Dynamics
2.3.1 Artificial Heart and Assist Devices Industry Trends
2.3.2 Artificial Heart and Assist Devices Market Drivers
2.3.3 Artificial Heart and Assist Devices Market Challenges
2.3.4 Artificial Heart and Assist Devices Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Heart and Assist Devices Players by Revenue
3.1.1 Global Top Artificial Heart and Assist Devices Players by Revenue (2018-2023)
3.1.2 Global Artificial Heart and Assist Devices Revenue Market Share by Players (2018-2023)
3.2 Global Artificial Heart and Assist Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Heart and Assist Devices Revenue
3.4 Global Artificial Heart and Assist Devices Market Concentration Ratio
3.4.1 Global Artificial Heart and Assist Devices Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Heart and Assist Devices Revenue in 2022
3.5 Artificial Heart and Assist Devices Key Players Head office and Area Served
3.6 Key Players Artificial Heart and Assist Devices Product Solution and Service
3.7 Date of Enter into Artificial Heart and Assist Devices Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Heart and Assist Devices Breakdown Data by Type
4.1 Global Artificial Heart and Assist Devices Historic Market Size by Type (2018-2023)
4.2 Global Artificial Heart and Assist Devices Forecasted Market Size by Type (2024-2029)
5 Artificial Heart and Assist Devices Breakdown Data by Application
5.1 Global Artificial Heart and Assist Devices Historic Market Size by Application (2018-2023)
5.2 Global Artificial Heart and Assist Devices Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Artificial Heart and Assist Devices Market Size (2018-2029)
6.2 North America Artificial Heart and Assist Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Artificial Heart and Assist Devices Market Size by Country (2018-2023)
6.4 North America Artificial Heart and Assist Devices Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Heart and Assist Devices Market Size (2018-2029)
7.2 Europe Artificial Heart and Assist Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Artificial Heart and Assist Devices Market Size by Country (2018-2023)
7.4 Europe Artificial Heart and Assist Devices Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Heart and Assist Devices Market Size (2018-2029)
8.2 Asia-Pacific Artificial Heart and Assist Devices Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Artificial Heart and Assist Devices Market Size by Region (2018-2023)
8.4 Asia-Pacific Artificial Heart and Assist Devices Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Heart and Assist Devices Market Size (2018-2029)
9.2 Latin America Artificial Heart and Assist Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Artificial Heart and Assist Devices Market Size by Country (2018-2023)
9.4 Latin America Artificial Heart and Assist Devices Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Heart and Assist Devices Market Size (2018-2029)
10.2 Middle East & Africa Artificial Heart and Assist Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Artificial Heart and Assist Devices Market Size by Country (2018-2023)
10.4 Middle East & Africa Artificial Heart and Assist Devices Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BiVACOR
11.1.1 BiVACOR Company Detail
11.1.2 BiVACOR Business Overview
11.1.3 BiVACOR Artificial Heart and Assist Devices Introduction
11.1.4 BiVACOR Revenue in Artificial Heart and Assist Devices Business (2018-2023)
11.1.5 BiVACOR Recent Development
11.2 SynCardia
11.2.1 SynCardia Company Detail
11.2.2 SynCardia Business Overview
11.2.3 SynCardia Artificial Heart and Assist Devices Introduction
11.2.4 SynCardia Revenue in Artificial Heart and Assist Devices Business (2018-2023)
11.2.5 SynCardia Recent Development
11.3 Jarvik Heart
11.3.1 Jarvik Heart Company Detail
11.3.2 Jarvik Heart Business Overview
11.3.3 Jarvik Heart Artificial Heart and Assist Devices Introduction
11.3.4 Jarvik Heart Revenue in Artificial Heart and Assist Devices Business (2018-2023)
11.3.5 Jarvik Heart Recent Development
11.4 CARMAT
11.4.1 CARMAT Company Detail
11.4.2 CARMAT Business Overview
11.4.3 CARMAT Artificial Heart and Assist Devices Introduction
11.4.4 CARMAT Revenue in Artificial Heart and Assist Devices Business (2018-2023)
11.4.5 CARMAT Recent Development
11.5 AbioMed
11.5.1 AbioMed Company Detail
11.5.2 AbioMed Business Overview
11.5.3 AbioMed Artificial Heart and Assist Devices Introduction
11.5.4 AbioMed Revenue in Artificial Heart and Assist Devices Business (2018-2023)
11.5.5 AbioMed Recent Development
11.6 LivaNova (Sorin)
11.6.1 LivaNova (Sorin) Company Detail
11.6.2 LivaNova (Sorin) Business Overview
11.6.3 LivaNova (Sorin) Artificial Heart and Assist Devices Introduction
11.6.4 LivaNova (Sorin) Revenue in Artificial Heart and Assist Devices Business (2018-2023)
11.6.5 LivaNova (Sorin) Recent Development
11.7 Getinge (Maquet)
11.7.1 Getinge (Maquet) Company Detail
11.7.2 Getinge (Maquet) Business Overview
11.7.3 Getinge (Maquet) Artificial Heart and Assist Devices Introduction
11.7.4 Getinge (Maquet) Revenue in Artificial Heart and Assist Devices Business (2018-2023)
11.7.5 Getinge (Maquet) Recent Development
11.8 Medtronic
11.8.1 Medtronic Company Detail
11.8.2 Medtronic Business Overview
11.8.3 Medtronic Artificial Heart and Assist Devices Introduction
11.8.4 Medtronic Revenue in Artificial Heart and Assist Devices Business (2018-2023)
11.8.5 Medtronic Recent Development
11.9 Terumo CV Group
11.9.1 Terumo CV Group Company Detail
11.9.2 Terumo CV Group Business Overview
11.9.3 Terumo CV Group Artificial Heart and Assist Devices Introduction
11.9.4 Terumo CV Group Revenue in Artificial Heart and Assist Devices Business (2018-2023)
11.9.5 Terumo CV Group Recent Development
11.10 Braile Biomedica
11.10.1 Braile Biomedica Company Detail
11.10.2 Braile Biomedica Business Overview
11.10.3 Braile Biomedica Artificial Heart and Assist Devices Introduction
11.10.4 Braile Biomedica Revenue in Artificial Heart and Assist Devices Business (2018-2023)
11.10.5 Braile Biomedica Recent Development
11.11 Tianjin Medical
11.11.1 Tianjin Medical Company Detail
11.11.2 Tianjin Medical Business Overview
11.11.3 Tianjin Medical Artificial Heart and Assist Devices Introduction
11.11.4 Tianjin Medical Revenue in Artificial Heart and Assist Devices Business (2018-2023)
11.11.5 Tianjin Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

BiVACOR
SynCardia
Jarvik Heart
CARMAT
AbioMed
LivaNova (Sorin)
Getinge (Maquet)
Medtronic
Terumo CV Group
Braile Biomedica
Tianjin Medical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂